WebIntroduction: Meconium aspiration syndrome is one of the most common causes of respiratory distress in the newborn. Risk of passage and aspiration of meconium … WebApr 28, 2024 · Background Steroids are a potential treatment for pulmonary inflammation in meconium aspiration syndrome (MAS). Objective To assess the efficacy and safety of steroids for the management of neonates with MAS. Design Systematic review and meta-analysis of randomized controlled trials (RCT). Data sources and selection criteria A …
(PDF) Meconium - ResearchGate
WebMeconium aspiration syndrome:incidence,associated risk factors and outcome-evidence from a multicentric study in low-resource settings in Nepal [J]. J Paediatr Child Health , 2024 , 56 ( 4 ): 630 - 635 . WebNov 21, 2024 · Background and Objectives: Meconium aspiration syndrome (MAS) is a condition caused by the aspiration of meconium-stainted amniotic fluid into the lungs, resulting in pulmonary inflammation, neonatal morbidity, and mortality. It is important that these MAS infants receive appropriate care to avoid further complications. Steroids have … nab low fee platinum
(PDF) Hydrocortisone therapy in meconium aspiration syndrome: …
WebDetails PDF download and online access $49.00 Details Check out Abstract Aim The aim of this study was to identify the incidence, risk factors and outcome associated with meconium aspiration syndrome (MAS). Methods An observational study was conducted in 12 public hospitals in Nepal from 1 July 2024 to 29 August 2024. WebKeywords: Dexamethasone, Meconium-stained amniotic fluid, Surfactant, Outcome. M econium aspiration syndrome (MAS) occurs in newborns born through meconium stained amniotic fluid [1]. While in the Vermont Oxford Network, MAS accounted for 1-2% of all NICU admissions with a mortality rate of 2-3% [2]; in India, MAS was the second WebINTRODUCTION Meconium aspiration syndrome (MAS) is defined as respiratory distress in newborn infants born through meconium-stained amniotic fluid (MSAF) whose symptoms … nabl the essentials